Cargando…
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056831/ https://www.ncbi.nlm.nih.gov/pubmed/33879175 http://dx.doi.org/10.1186/s13054-021-03568-8 |
| _version_ | 1783680730443808768 |
|---|---|
| author | Le Daré, Brendan Boglione-Kerrien, Christelle Reizine, Florian Gangneux, Jean-Pierre Bacle, Astrid |
| author_facet | Le Daré, Brendan Boglione-Kerrien, Christelle Reizine, Florian Gangneux, Jean-Pierre Bacle, Astrid |
| author_sort | Le Daré, Brendan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8056831 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80568312021-04-20 Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis Le Daré, Brendan Boglione-Kerrien, Christelle Reizine, Florian Gangneux, Jean-Pierre Bacle, Astrid Crit Care Research Letter BioMed Central 2021-04-20 /pmc/articles/PMC8056831/ /pubmed/33879175 http://dx.doi.org/10.1186/s13054-021-03568-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Research Letter Le Daré, Brendan Boglione-Kerrien, Christelle Reizine, Florian Gangneux, Jean-Pierre Bacle, Astrid Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis |
| title | Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis |
| title_full | Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis |
| title_fullStr | Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis |
| title_full_unstemmed | Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis |
| title_short | Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis |
| title_sort | toward the personalized and integrative management of voriconazole dosing during covid-19-associated pulmonary aspergillosis |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056831/ https://www.ncbi.nlm.nih.gov/pubmed/33879175 http://dx.doi.org/10.1186/s13054-021-03568-8 |
| work_keys_str_mv | AT ledarebrendan towardthepersonalizedandintegrativemanagementofvoriconazoledosingduringcovid19associatedpulmonaryaspergillosis AT boglionekerrienchristelle towardthepersonalizedandintegrativemanagementofvoriconazoledosingduringcovid19associatedpulmonaryaspergillosis AT reizineflorian towardthepersonalizedandintegrativemanagementofvoriconazoledosingduringcovid19associatedpulmonaryaspergillosis AT gangneuxjeanpierre towardthepersonalizedandintegrativemanagementofvoriconazoledosingduringcovid19associatedpulmonaryaspergillosis AT bacleastrid towardthepersonalizedandintegrativemanagementofvoriconazoledosingduringcovid19associatedpulmonaryaspergillosis |